Amid growing demand for waiving Intellectual Rights over Covid-19 vaccines and even granting compulsory licences to Pharmaceutical companies to manufacture the vaccines to tide over...
Continue ReadingPlasma therapy on Covid-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped...
Continue ReadingThe domestic pharmaceuticals market has seen a rebound in April, with sales growing 51.5 per cent over last year, thanks to the low base of...
Continue ReadingAs the country grapples with the second wave of Covid-19, vaccine maker Biological E is gearing up to churn out 75 to 80 million doses...
Continue ReadingIndian regulators have given emergency use authorization for an antibody-drug cocktail developed by Roche and Regeneron to treat COVID-19, Roche’s local partner said. The Central...
Continue ReadingAmidst all the bad Covid news coming out of India there could be a glimmer of hope. As reported previously American Pharma major Merck has...
Continue ReadingMaharashtra is on a massive treasure hunt. The treasure? Remdesivir! Typically 5 to 8 vials of the antiviral injection are needed to treat moderate to...
Continue ReadingAlbert Bourla, chairman and CEO of Pfizer, said he hopes the company’s coronavirus oral antiviral therapeutic in early-stage trials will be ready by the end...
Continue ReadingIn 2019, drug pricing was expected to be a top drug industry issue heading into the New Year. Things changed in 2020. The pharma industry...
Continue Reading